PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0006142|breast cancer |
| Sentences | 28 |
| PubMedID- 25979298 | Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. |
| PubMedID- 25083463 | Metabolic syndrome in breast cancer. |
| PubMedID- 25890160 | Conclusion: dermatomyositis can be a clinical manifestation of a paraneoplastic syndrome in patients with breast cancer. |
| PubMedID- 19847590 | Aosd has been reported as one of paraneoplastic syndromes associated with breast cancer. |
| PubMedID- 26030767 | Presence of metabolic syndrome was associated with significantly increased breast cancer risk in all women (hr 1.52, 95%ci 1.14-2.02). |
| PubMedID- 24319454 | Due to a higher prevalence of metabolic syndrome in breast cancer survivors, lifestyle interventions are needed to prevent chronic diseases associated with obesity. |
| PubMedID- 26155297 | Our patient presented with dm as a paraneoplastic syndrome associated with metastatic breast cancer. |
| PubMedID- 26385214 | Another large recent meta-analysis found that the presence of metabolic abnormalities (i.e., metabolic syndrome) is associated with an increased breast cancer risk in adult women [18]. |
| PubMedID- 25233884 | Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. |
| PubMedID- 26227626 | Even though motor neuron diseases are not typical paraneoplastic syndromes, association with breast cancer had been regularly reported [37–41]. |
| PubMedID- 24783905 | We must point out that cardiovascular disease risk conferred by metabolic syndrome may increase with breast cancer treatment. |
| PubMedID- 25653879 | Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis. |
| PubMedID- 19851862 | A statistically significant association of triple-negative breast cancer with the metabolic syndrome was observed. |
| PubMedID- 21249376 | Objective: this study was aimed to assess the prevalence of metabolic syndrome in patients with breast cancer and the independent effect of metabolic syndrome on breast cancer risk. |
| PubMedID- 23061769 | Metabolic syndrome is associated with both increased breast cancer risk and high mortality rates in postmenopausal cases [45, 46]. |
| PubMedID- 25095302 | The case report features a patient who had a diagnosis of a common type of breast cancer with an uncommon neurologic syndrome. |
| PubMedID- 24344007 | The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients. |
| PubMedID- 22740197 | Several studies have examined the association of the individual components of the metabolic syndrome with breast cancer. |
| PubMedID- 23275775 | breast cancer presents with a paraneoplastic neurologic syndrome. |
| PubMedID- 21490772 | Two population-based screening surveys involving norwegian women found that low hdl-cholesterol, as part of the metabolic syndrome, is associated with increased post-menopausal breast cancer risk, and hdl-cholesterol association was confined to women in the heavier subgroup with body mass index (bmi) ≥25 kg/m2 [50]. |
| PubMedID- 20931277 | Polymyositis (pm) is a very rare paraneoplastic syndrome in association with breast cancer, here we present a breast cancer patient with a sudden onset of respiratory failure caused by pm. |
| PubMedID- 23227958 | The authors hypothesized that the higher prevalence of abdominal obesity and metabolic syndrome among women with triple-negative breast cancer and its link to adrenergic dysregulation and also high expression of beta-adrenergic receptors in triple-negative breast cancer cell lines could make these patients particularly sensitive to beta-blocker treatment. |
| PubMedID- 23981814 | Results from those studies reported statistically significant higher prevalence of metabolic syndrome in breast cancer patients with respect to healthy ones (35% vs. 19%) after menopause. |
| PubMedID- 26337050 | Although a protective effect of oral contraceptives against ovarian cancer is nearly proven, their routine prophylactic use is no longer recommended due to the possible increased relative risk of breast cancer in patients with hboc syndrome [5]. |
| PubMedID- 26175188 | Adherence to wcrf/aicr cancer prevention recommendations and metabolic syndrome in breast cancer patients. |
| PubMedID- 25979299 | Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. |
| PubMedID- 23050155 | breast cancer patients with metabolic syndrome undergoing chemotherapy were found to have an overall poor response to treatment and those patients who specifically had high blood glucose levels were noted to have increased rates of disease progression [2]. |
| PubMedID- 23113882 | Therefore, there may be significant differences in icam and vcam in patients with and without breast cancer (regardless of obesity and metabolic syndrome) and this should be investigated in future studies. |
Page: 1